Literature DB >> 19160988

[Endovascular treatment of carotid-cavernous fistula type A with platinium coils].

Slobodan Culafić1, Robert Juszkat, Sinisa Rusović, Dara Stefanović, Ljubodrag Minić, Milan Spaić.   

Abstract

BACKGROUND: Carotid-cavernous fistulas are abnormal communications between carotid arteries or their branches and the cavernous system caused mostly by trauma. Posttraumatic fistulas represent 70% of all carotid-cavernous fistulas and they are mostly high-flow shunts (type A). This type gives characteristic eye symptoms. CASE REPORT: This paper presents a 44-year old male patient with carotid-cavernous fistula as a result of penetrating head injury. In clinical presentation the patient had exophthalmos, conjunctival chemosis and weakening of vision on the right eye, headache and diplopia. Digital subtracted angiography showed high-flow carotid-cavernous fistula, which was vascularised from the left carotid artery and from vertebrobasilar artery. Endovascular embolization with platinum coils was performed through the transarterial route (endoarterial approach). Check angiogram confirmed that the fistula was closed and that no new communications developed.
CONCLUSION: Embolization of complex carotid-cavernous fistula type A was successfully performed with platinum coils by endovascular approach.

Entities:  

Mesh:

Year:  2008        PMID: 19160988     DOI: 10.2298/vsp0812923c

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  2 in total

1.  Triple coaxial catheter technique for transfacial superior ophthalmic vein approach for embolization of dural carotid-cavernous fistula.

Authors:  M-H Yuen; K-M Cheng; Y-L Cheung; C-M Chan; S C H Yu; G K C Wong; W-S Poon
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

2.  Hemicranial Cough-Induced Headache as a First Symptom of a Carotid-Cavernous Fistula-Case Report.

Authors:  Svetlana Simić; Ljiljana Radmilo; José R Villar; Aleksandar Kopitović; Dragan Simić
Journal:  Medicina (Kaunas)       Date:  2020-04-23       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.